Doxorubicin, mitomycin-C, and 5-fluorouracil (DMF) in the treatment of metastatic hormonal refractory adenocarcinoma of the prostate, with a note on the staging of metastatic prostate cancer.
- 1 June 1983
- journal article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 1 (6) , 368-379
- https://doi.org/10.1200/jco.1983.1.6.368
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: